Additional information
Off white Powder
154127-19-2
ACI-022313
126.9-128.0ºC
C12H21N3O5S3
383.51
Ambient
2-8°C
Glaucoma or ocular hypertension
Pharmaceutical Impurity Standards
(S)-(-)-4-ethylamino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine-6-sulfonamide-1,1-dioxide
(S)-(-)-4-ethylamino-2,3-dihydro-2-(3-methoxypropyl)-4H-thieno-[3,2,e]-thiazine-6-sulfonamide-1,1-dioxide
(S)-Brinzolamide;Brinzolamide USP Related Compound A





![N-BOC-N-DESHYDROXYETHYL DASATINIB (25 mg) (2-Methyl-2-propanyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinecarboxylate )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)